MA03.08 Impact of COVID-19 Pandemic in the Diagnosis and Prognosis of Lung Cancer

Reyes, Roxana; López-Castro, Rafael; Auclin, Édouard; Garcia, Thiago Ghorayeb; Chourio, M.J.; Rodríguez, Alejandro; López, Luis Fernández; Laguna, Javier; Lucena, Carmen; Molins, Laureano; Martı́nez, Daniel; Casas, Francesc; Mayoral, María; Teixidó, Cristina; Prat, Ana Muntañola; Viñolas, Núria; Reguart, Noemı́; Mezquita, Laura

doi:10.1016/j.jtho.2021.01.219

Cited by 22 publications

(16 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Fear related to contracting COVID-19, quarantining, and stay-at-home orders have caused patients to be more apprehensive to seek care for emergent issues [ 2 ]. This finding is further supported by the study conducted by Dr. Reyes and colleagues that found a 38% decrease in new lung cancer cases in 2020 compared to the pre-COVID-19 era [ 14 ]. According to Quebec Ministry of Health, about 4100 people may have gone undiagnosed with all cancer types during the pandemic.…”

Section: Discussionsupporting

confidence: 59%

The Impact of COVID-19 on the Diagnosis and Treatment of Lung Cancer at a Canadian Academic Center: A Retrospective Chart Review

et al. 2021

View full text Add to dashboard Cite

The large burden of COVID-19 on health care systems worldwide has raised concerns among medical oncologists about the impact of COVID-19 on the diagnosis and treatment of lung cancer patients. In this retrospective cohort study, we investigated the impact of COVID-19 on lung cancer diagnosis and treatment before and during the COVID-19 era. New lung cancer diagnoses decreased by 34.7% during the pandemic with slightly more advanced stages of disease, there was a significant increase in the utilization of radiosurgery as the first definitive treatment, and a decrease in both systemic treatment as well as surgery compared to the pre-COVID-19 era. There was no significant delay in starting chemotherapy and radiation treatment during the pandemic compared to pre-COVID-19 time. However, we observed a delay to lung cancer surgery during the pandemic time. COVID-19 seems to have had a major impact at our lung cancer center on the diagnoses and treatment patterns of lung cancer patients. Many oncologists fear that they will see an increase in newly diagnosed lung cancer patients in the coming year. This study is still ongoing and further data will be collected and analyzed to better understand the total impact of the COVID-19 pandemic on our lung cancer patient population.

show abstract

Section: Discussionsupporting

confidence: 59%

The Impact of COVID-19 on the Diagnosis and Treatment of Lung Cancer at a Canadian Academic Center: A Retrospective Chart Review

et al. 2021

View full text Add to dashboard Cite

show abstract

“…Literature detailing the impact of COVID-19 on new cancer diagnoses and prognosis is emerging, with fewer LC cases diagnosed during the pandemic period compared to the prior year and an increase in symptomatic and severe cases of LC diagnosed during the pandemic period. 10,11 To date, no standard-of-care approach exists for treating patients with LC during the pandemic. Several organizations and groups of experts shared general recommendations for providers early in the pandemic.…”

Section: Discussionmentioning

confidence: 99%

Care disruptions among patients with lung cancer: A COVID-19 and cancer outcomes study

et al. 2021

View full text Add to dashboard Cite

This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

show abstract

“…Most centres had transitioned to either hybrid or fully virtual meetings, with only 12 sites continuing face-to-face meetings, some citing benefit and some drawback(s) with these approaches. This survey was not designed to investigate the impact in detail, although the free-text comments supported other recent reports that have demonstrated a decline in diagnostic procedures performed for lung cancer along with lower rates of diagnosis, reduction in clinical trial participation and increased 30-day mortality 14 29…”

Section: Discussionmentioning

confidence: 95%

Hospital-based multidisciplinary lung cancer care in Australia: a survey of the landscape in 2021

et al. 2022

View full text Add to dashboard Cite

IntroductionLung cancer is the leading cause of cancer death in Australia and has the highest cancer burden. Numerous reports describe variations in lung cancer care and outcomes across Australia. There are no data assessing compliance with treatment guidelines and little is known about lung cancer multidisciplinary team (MDT) infrastructure around Australia.MethodsClinicians from institutions treating lung cancer were invited to complete an online survey regarding the local infrastructure for lung cancer care and contemporary issues affecting lung cancer.ResultsResponses from 79 separate institutions were obtained representing 72% of all known institutions treating lung cancer in Australia. Most (93.6%) held a regular MDT meeting although recommended core membership was only achieved for 42/73 (57.5%) sites. There was no thoracic surgery representation in 17/73 (23.3%) of MDTs and surgery was less represented in regional and low case volume centres. Specialist nurses were present in just 37/79 (46.8%) of all sites. Access to diagnostic and treatment facilities was limited for some institutions. IT infrastructure was variable and most sites (69%) do not perform regular audits against guidelines. The COVID-19 pandemic has driven most sites to incorporate virtual MDT meetings, with variable impact around the country. Clinician support for a national data-driven approach to improving lung cancer care was unanimous.DiscussionThis survey demonstrates variations in infrastructure support, provision and membership of lung cancer MDTs, in particular thoracic surgery and specialist lung cancer nurses. This heterogeneity may contribute to some of the well-documented variations in lung cancer outcomes in Australia.

show abstract

MA03.08 Impact of COVID-19 Pandemic in the Diagnosis and Prognosis of Lung Cancer

Cited by 22 publications

References 0 publications

The Impact of COVID-19 on the Diagnosis and Treatment of Lung Cancer at a Canadian Academic Center: A Retrospective Chart Review

The Impact of COVID-19 on the Diagnosis and Treatment of Lung Cancer at a Canadian Academic Center: A Retrospective Chart Review

Care disruptions among patients with lung cancer: A COVID-19 and cancer outcomes study

Hospital-based multidisciplinary lung cancer care in Australia: a survey of the landscape in 2021

Contact Info

Product

Resources

About